Clinical Trials
3
Active:1
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (66.7%)Phase 1
1 (33.3%)RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Phase 2
Not yet recruiting
- Conditions
- Adjustment Disorder
- Interventions
- Drug: RE104 for Injection
- First Posted Date
- 2025-06-03
- Last Posted Date
- 2025-06-03
- Lead Sponsor
- Reunion Neuroscience Inc
- Target Recruit Count
- 100
- Registration Number
- NCT07002034
RE104 Clinical Lactation Study
Phase 1
Completed
- Conditions
- Lactation
- Interventions
- Drug: RE104 for Injection
- First Posted Date
- 2024-10-26
- Last Posted Date
- 2025-06-12
- Lead Sponsor
- Reunion Neuroscience Inc
- Target Recruit Count
- 14
- Registration Number
- NCT06659263
- Locations
- 🇺🇸
PPD Inc, Las Vegas, Nevada, United States
RE104 Safety and Efficacy Study in Postpartum Depression
Phase 2
Active, not recruiting
- Conditions
- Postpartum Depression
- Interventions
- Drug: RE104 for Injection
- First Posted Date
- 2024-04-02
- Last Posted Date
- 2025-06-12
- Lead Sponsor
- Reunion Neuroscience Inc
- Target Recruit Count
- 84
- Registration Number
- NCT06342310
- Locations
- 🇺🇸
Reunion Investigational Site, Madison, Wisconsin, United States
News
No news found